Status:

RECRUITING

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Yale University

Conditions:

Heart Failure With Reduced Ejection Fraction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

An increasing number of guideline-directed medical therapies (GDMT) have been developed for patients with chronic heart failure with reduced ejection fraction (HFrEF). When used in combination at reco...

Detailed Description

I-I-CAPTAIN-HF is a multi-site, type-2 hybrid implementation-effectiveness trial conducted at 5 sites: the University of Colorado (central site), Yale University, Northwestern University, University o...

Eligibility Criteria

Inclusion

  • Clinician:
  • Clinician (MD, PA, NP) who practices in cardiology outpatient clinics
  • Regularly sees patients with left ventricular ejection fraction (EF) \</=40%, where their panel of patients over the last year included at least 25 patients with heart failure with reduced ejection fraction (HFrEF)
  • Patient:
  • Age \> 18 years
  • LVEF \</=40% on most recent cardiology imaging study
  • Has had a routine cardiology outpatient clinic appointment in the previous 12 months
  • Not on all 4 pillars of GDMT at optimal doses: (1) beta blockers, (2) angiotensin receptor-neprilysin inhibitor/angiotensin converting enzyme inhibitor/angio-tensin receptor blocker, (3) aldosterone receptor antagonists, (4) sodium-glucose co-transporter

Exclusion

  • Patient:
  • Has a left ventricular assist device
  • Under evaluation for or listed for transplant (or s/p transplant)
  • Glomerular filtration rate (GFR) less than 15
  • On IV inotropes
  • On hospice care
  • Non-English or Non-Spanish speaking

Key Trial Info

Start Date :

March 6 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2028

Estimated Enrollment :

2200 Patients enrolled

Trial Details

Trial ID

NCT06526988

Start Date

March 6 2025

End Date

September 1 2028

Last Update

June 12 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Sutter Health

Walnut Creek, California, United States, 94596

2

University of Colorado

Aurora, Colorado, United States, 80045

3

Yale University

New Haven, Connecticut, United States, 06510

4

Northwestern University

Chicago, Illinois, United States, 60611